Article info
New disease loci
Short report
VPS53 mutations cause progressive cerebello-cerebral atrophy type 2 (PCCA2)
- Correspondence to Dr Ohad S Birk, Genetics Institute, Soroka Medical Center, Beer-Sheva 84101, Israel; obirk{at}bgu.ac.il
Citation
VPS53 mutations cause progressive cerebello-cerebral atrophy type 2 (PCCA2)
Publication history
- Received May 23, 2013
- Revised January 6, 2014
- Accepted February 3, 2014
- First published February 27, 2014.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions